We are live on ! Find out more
MM

MWG Management Portfolio holdings

AUM $81.3M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
-23.56%
1 Year Est. Return
+2.28%
3 Year Est. Return
-59.16%
5 Year Est. Return
-10.97%
10 Year Est. Return
AUM
$196M
AUM Growth
-$63.7M
Cap. Flow
+$33.2M
Cap. Flow %
16.93%
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PRME icon
Prime Medicine
PRME
+$33.2M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BEAM icon
1
Beam Therapeutics
BEAM
$2.74B
$91.8M 46.86%
2,346,934
LYEL icon
2
Lyell Immunopharma
LYEL
$315M
$70M 35.72%
1,008,117
PRME icon
3
Prime Medicine
PRME
$558M
$34.1M 17.42%
+1,835,876
New +$33.2M

Similar funds

MWG Management's Q4 2022 Portfolio in Review

As of Q4 2022, MWG Management held 3 positions worth $196M, down 25% from $260M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

MWG Management deployed $33.2M of net new capital in Q4 2022, opening 1 new position. Its largest new stake was Prime Medicine: 1,835,876 shares worth $34.1M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • MWG Management's largest Q4 2022 buy was Prime Medicine: 1,835,876 shares worth $34.1M.
  • MWG Management's ten largest holdings make up 100% of its $196M portfolio in Q4 2022.
  • MWG Management opened 1 new position and closed 0 in Q4 2022.
  • MWG Management's portfolio value fell 25% quarter-over-quarter to $196M.

Based on MWG Management's 13F filing for Q4 2022, filed 14 Feb 2023.